Financial Performance - Operating revenue for the reporting period was ¥45,105,904.67, down 78.65% compared to the same period last year[8]. - Net profit attributable to shareholders of the listed company was ¥1,571,594.94, a decrease of 96.74% year-on-year[8]. - Basic earnings per share were ¥0.0186, down 97.56% year-on-year[8]. - The total comprehensive income for the current period is ¥65,767,198.16, reflecting a decrease of 50.1% compared to ¥131,935,706.03 in the previous period[80]. - The net profit for the current period is ¥67,547,642.28, a decline of 55.7% from ¥152,219,541.74 in the previous period[70]. - Total operating revenue for the current period is CNY 45,105,904.67, a decrease of 78.7% compared to CNY 211,314,407.45 in the previous period[49]. - The company reported a financial expense of CNY -21,765,921.59, an increase from CNY -12,411,152.58 in the previous period[70]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,813,735,564.03, an increase of 130.41% compared to the end of the previous year[8]. - The total assets increased significantly, with current assets totaling ¥1,652,562,319.21, up from ¥626,666,634.54 in the previous year[33]. - The total liabilities decreased from ¥100,114,060.15 to ¥61,778,728.86, a reduction of about 38%[39]. - Current liabilities decreased from ¥94,016,719.46 to ¥57,037,323.09, a reduction of about 39%[39]. - The total equity attributable to shareholders increased to ¥1,734,157,604.89 from ¥667,628,335.40, reflecting a growth of around 160%[42]. - The company's cash and cash equivalents increased by 280.52% to ¥1,399,756,953.42, primarily due to fundraising in May 2020[20]. Cash Flow - The net cash flow from operating activities was ¥49,283,418.99, an increase of 45.92% compared to the previous year[8]. - Cash flow from operating activities is ¥44,114,223.46, down 57.0% from ¥102,789,220.94 in the previous period[83]. - Total cash inflow from financing activities is ¥1,008,113,315.51, significantly higher than ¥6,822,292.88 in the previous period[85]. - The company received $51.05 million in cash related to other operating activities, a significant increase from $10.43 million in the previous period[89]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 19,075[12]. - Major shareholder Jiang Weikai holds 36.70% of the shares, totaling 30,943,875 shares[13]. Government Support - The company received government subsidies amounting to ¥4,618,564.90 during the reporting period[8]. Research and Development - Research and development expenses for the current period are CNY 7,365,590.68, a decrease of 25.0% from CNY 9,818,320.41 in the previous period[52]. - Research and development expenses for the current period are ¥21,336,648.23, down 21.3% from ¥27,098,840.97 in the previous period[77]. Other Financial Metrics - The weighted average return on net assets was 0.09%, a decrease of 7.96% compared to the previous year[8]. - The company reported an increase in undistributed profits to ¥483,768,660.13 from ¥417,021,708.54, an increase of about 16%[42]. - The company recorded a fair value change loss of CNY -228,753.35 in the current period, compared to a gain of CNY 304,314.43 in the previous period[63].

Financial Performance - The company's operating revenue for the first half of 2020 was ¥257,245,233.19, a decrease of 40.17% compared to ¥429,967,151.64 in the same period last year[25]. - The net profit attributable to shareholders of the listed company was ¥65,175,356.65, down 36.09% from ¥101,974,471.58 in the previous year[25]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥62,090,629.82, a decrease of 38.15% compared to ¥100,395,259.97 in the same period last year[25]. - The net profit for the period was ¥65,684,803.78, down 36.83% year-on-year[58]. - The company's total revenue for the reporting period was CNY 257,245,233.19, a decrease of 40.17% compared to CNY 429,967,151.64 in the same period last year, primarily due to reduced market demand caused by the pandemic[63]. - The net cash flow from operating activities was -5,169,195.53 CNY, a decrease of 107.49% compared to the previous period[28]. - Basic and diluted earnings per share decreased by 39.45%, from 1.6124 CNY to 0.9763 CNY[28]. - The weighted average return on equity dropped to 7.52%, down 11.99 percentage points from 19.51%[28]. - The company reported a decrease in other receivables to CNY 2,521,492.24 from CNY 4,838,420.70, indicating a decline of approximately 47.9%[160]. - The total comprehensive income for the first half of 2020 was CNY 62,642,097.03, down from CNY 89,877,213.39 in the first half of 2019[187]. Capital and Shareholder Information - The company's registered capital increased from ¥63,245,000 to ¥84,327,000, reflecting a change in company type to a listed company[24]. - The company issued 21,082,000 shares of RMB ordinary stock, increasing total shares from 63,245,000 to 84,327,000[135]. - The total number of ordinary shareholders at the end of the reporting period was 25,800[139]. - The largest shareholder, Jiang Weikai, holds 36.70% of the shares, totaling 30,943,875 shares[139]. - The company's stock was listed on the Shenzhen Stock Exchange on May 20, 2020, at a price of 52.09 RMB per share[138]. - The total number of shares with unlimited sale conditions is 21,082,000, representing 25.00% of total shares[135]. Assets and Liabilities - Total assets increased by 135.27%, reaching 1,851,958,646.49 CNY compared to 787,178,435.13 CNY at the end of the previous year[28]. - Net assets attributable to shareholders rose by 159.20%, from 667,628,335.40 CNY to 1,730,495,809.73 CNY[28]. - The company's total assets increased to CNY 1,807,892,559.02, up from CNY 743,613,471.13 year-over-year[176]. - Total liabilities rose to CNY 106,394,805.95, compared to CNY 102,471,160.19 in the previous year[176]. - The equity attributable to shareholders increased significantly to CNY 1,730,495,809.73 from CNY 667,628,335.40, representing a growth of about 159.0%[165]. Research and Development - The company has invested CNY 17,038,840.08 in R&D during the reporting period, a decrease of 19.08% compared to CNY 21,055,541.02 in the previous year[63]. - The company has a total of 438 domestic patents and 47 overseas patents, showcasing its commitment to technological innovation[49]. - The company holds a total of 438 domestic patents, including 44 invention patents, 226 utility model patents, and 168 design patents, as well as 47 overseas patents and 254 software copyrights[60]. - The company reported a decrease in research and development expenses to CNY 14,793,131.03 from CNY 18,814,042.69, reflecting a reduction of 21.4%[184]. Market and Strategic Focus - The company continues to focus on its core business and aims to enhance its market position despite the challenges faced[6]. - The company has established a stable procurement model combining order-based and risk-based purchasing to ensure production continuity[38]. - The company has closely monitored the global pandemic trends and is preparing for market recovery by investing in new technologies and products[62]. - The company aims to expand its domestic market presence by promoting intelligent building lighting products and undertaking more cultural tourism project contracts[84]. - The company is actively developing and marketing UV disinfection lamps to meet pandemic-related demands and improve profitability[84]. Dividend and Shareholder Communication - The company plans not to distribute cash dividends or bonus shares for the reporting period[6]. - The company has not conducted any investor meetings, communications, or interviews during the reporting period[93]. - The semi-annual financial report has not been audited[98]. - The company has not faced any media scrutiny during the reporting period[105]. Operational Challenges - The company faced significant uncertainties in achieving its future strategic goals due to market conditions[6]. - The company has established a pandemic prevention and control task force to mitigate the impact of COVID-19 on its operations[84]. - The company has faced a 25% tariff on products exported to the U.S. due to ongoing trade tensions, which could impact sales and profitability[85]. - The company is focusing on enhancing its market competitiveness and negotiating with clients to share tariff costs[86].